Risk factors for hepatitis C virus infection in patients on long-term hemodialysis

Nasir Khokhar1, Ali Yawar Alam, Farah Naz

  • 1Department of Medicine/Community Medicine, Shifa International Hospital and Shifa College of Medicine, Islamabad, Pakistan. drnkhokhar@yahoo.com

Insights

Hepatitis C virus (HCV) infection affects 23.7% of hemodialysis patients. A history of dialysis exceeding two years significantly increases the risk of acquiring HCV infection in this vulnerable population.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) poses a significant health risk, particularly to patients undergoing long-term hemodialysis.
  • Identifying risk factors for HCV acquisition in hemodialysis patients is crucial for implementing effective prevention strategies.

Purpose of the Study:

  • To determine the prevalence of HCV infection among hemodialysis patients at Shifa International Hospital.
  • To investigate the association between various risk factors and HCV infection in this patient cohort.

Main Methods:

  • A cross-sectional analytical study was conducted.
  • Medical records of 97 hemodialysis patients from January 2002 to June 2003 were reviewed.
  • Data on anti-HCV status and potential risk factors were collected and analyzed.

Main Results:

  • The overall prevalence of anti-HCV antibodies was 23.7%.
  • Patients with a history of dialysis exceeding two years showed a significantly higher prevalence of HCV infection (43.5% vs. 9.5%).
  • Increasing duration of dialysis was significantly associated with an increased risk of HCV acquisition (adjusted p-value 0.002).

Conclusions:

  • HCV infection is prevalent among hemodialysis patients at Shifa International Hospital, with a positivity rate of 23.7%.
  • A history of dialysis for over two years emerged as a significant risk factor for HCV acquisition in this population.
  • These findings underscore the need for enhanced infection control measures in hemodialysis units.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...